The response to hepatitis B vaccine: Does it differ in celiac disease?

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 7, 2010, Pages 787-793

  Ertem, Deniz ^a   Gonen, Ismail ^a   Tanidir, Cansaran ^c   Ugras, Meltem ^a   Yildiz, Aysegul ^b   Pehlivanoǧlu, Ender ^a   Eksioglu Demiralp, Emel ^c  

^a Division of Pediatric GastroenterologyHepatology and Nutrition   (Turkey)

^b Division of Pediatric Allergy and Immunology   (Turkey)

^c MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

celiac disease; children; hepatitis B; human leukocyte antigen type; vaccine response

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; HEPATITIS B ANTIBODY; HLA ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; FEMALE; GENOTYPE; GLUTEN FREE DIET; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; BLOOD; DIET THERAPY; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; IMMUNOLOGY; PROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIET, GLUTEN-FREE; FEMALE; HAPLOTYPES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HLA ANTIGENS; HUMANS; MALE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77953981535     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32832e9d41     Document Type: Article

References (32)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2:395-403.
2. Gabbuti A, Romanò L, Blanc P, Meacci F, Amendola A, Mele A, et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 2007; 25:3129-3132.
3. Lin YC, Chang MH, Ni YH, Hsu HY. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 2003; 187:134-138.
4. Yuen MF, Lim WL, Chan AO, Yuen MF, Lim WL, Chan AO, et al. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clin Gastroenterol Hepatol 2004; 2:941-945.
5. Zannetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379-1384.
6. Chen DS. Long-term protection of hepatitis B vaccine: lessons from Alaskan experience after 15 years. Ann Intern Med 2005; 142:384-385.
7. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 2002; 35:1368-1375.
8. McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142:333-341.
9. Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321:708-712.
10. Sjogren MH. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med 2005; 118:345-395.
11. Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000; 97:234-240.
12. King AL, Ciclitira PJ. Celiac disease: strongly heritable, oligogenic, but genetically complex. Mol Genet Metab 2000; 71:70-75.
13. Kaur G, Sarkar N, Bhatnagar S, Kumar S, Rapthap CC, Bhan MK, et al. Pediatric celiac disease in India is associated with multiple DR3-DQ2 haplotypes. Hum Immunol 2002; 63:677-682.
14. Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 1993; 105:910-922.
15. Lundin KEA, Gjertsen HA, Scott H, Sollid LM, Thorsby E. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol 1994; 41:24-27.
16. Kaukinen K, Partanen J, Maki M, Collin P. HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 2002; 97:695-699.
17. Noh KW, Poland GA, Murray JA. Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol 2003; 98:2289-2292.
18. Park SD, Markowitz J, Pettei M, Weinstein T, Sison CP, Swiss SR, et al. Failure to respond to hepatitis B vaccine in children with celiac disease. J Pediatr Gastroenterol Nutr 2007; 44:431-435.
19. Kagnoff MF. Celiac disease: a gastrointestinal disease with environmental, genetic and immunologic components. Gastroenterol Clin N Am 1992; 21:405-425.
20. Ploski R, Ascher H, Sollid LM. HLA genotypes and the increased incidence of coeliac disease in Sweden. Scand J Gastroenterol 1996; 31:1092-1097.
21. Bergseng E, Sidney J, Sette A, Sollid LM. Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules. Hum Immunol 2008; 69:94-100.
22. Stepniak D, Wiesner M, de Ru AH, Moustakas AK, Drijfhout JW, Papadopoulos GK, et al. Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2. J Immunol 2008; 180:3268-3278.
23. FitzSimons D, François G, Hall A, McMohan B, Meheus A, Zanetti A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23:4158-4166.
24. Hadler SC, Margolis HS. Hepatitis B immunization: vaccine types, efficacy, and indications for immunization. Curr Clin Top Infect Dis 1992; 12:282-308.
25. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303:833-841.
26. Goncalves L, Albarran B, Salmen S, Borges L, Fields H, Montes H, et al. The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation. Virology 2004; 326:20-28.
27. Walker M, Szmuness W, Stevens CF, Rubinstein P. Genetics of anti-HBs responsiveness. HLA-DR7 and nonresponsiveness to hepatitis vaccination. Transfusion 1981; 21:601-606.
28. Höhler T, Reuss E, Evers N, Dietrich E, Rittner C, Freitag CM, et al. Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet 2002; 360:991-995.
29. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003; 77:12083-12087.
30. Godkin A, Davenport M, Hill AV. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005; 41:1383-1390.
31. Nemes E, Lefler E, Szegedi L, Kapitá ny A, Kovács JB, Balogh M, et al. Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease. Pediatrics 2008; 121:e1570-e1576.
32. Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004; 39:978-988.